Chloroquine Differentially Modulates Coronary Vasodilation in Control and Diabetic Mice
Overview
Authors
Affiliations
Background And Purpose: Chloroquine is a traditional medicine to treat malaria. There is increasing evidence that chloroquine not only induces phagocytosis but regulates vascular tone. Few reports investigating the effect of chloroquine on vascular responsiveness of coronary arteries have been made. In this study, we examined how chloroquine affected endothelium-dependent relaxation in coronary arteries under normal and diabetic conditions.
Experimental Approach: We isolated coronary arteries from mice and examined endothelium-dependent relaxation (EDR). Human coronary endothelial cells and mouse coronary endothelial cells isolated from control and diabetic mouse (TALLYHO/Jng [TH] mice, a spontaneous type 2 diabetic mouse model) were used for the molecular biological or cytosolic NO and Ca measurements.
Key Results: Chloroquine inhibited endothelium-derived NO-dependent relaxation but had negligible effect on endothelium-derived hyperpolarization (EDH)-dependent relaxation in coronary arteries of control mice. Chloroquine significantly decreased NO production in control human coronary endothelial cells partly by phosphorylating eNOS (an inhibitory phosphorylation site of eNOS) and attenuating the rise of cytosolic Ca concentration after stimulation. EDR was significantly inhibited in diabetic mice in comparison to control mice. Interestingly, chloroquine enhanced EDR in diabetic coronary arteries by, specifically, increasing EDH-dependent relaxation due partly to its augmenting effect on gap junction activity in diabetic mouse coronary endothelial cells.
Conclusions And Implications: These data indicate that chloroquine affects vascular relaxation differently under normal and diabetic conditions. Therefore, the patients' health condition such as coronary macrovascular or microvascular disease, with or without diabetes, must be taken account into the consideration when selecting chloroquine for the treatment of malaria.
Mechanisms Underlying the Effects of Chloroquine on Red Blood Cells Metabolism.
Russo A, Patane G, Putaggio S, Lombardo G, Ficarra S, Barreca D Int J Mol Sci. 2024; 25(12).
PMID: 38928131 PMC: 11203553. DOI: 10.3390/ijms25126424.
Arslan S, Dogan M, Cam S, Omar I, Uysal F, Parlar A Turk J Med Sci. 2022; 52(3):848-857.
PMID: 36326331 PMC: 10390209. DOI: 10.55730/1300-0144.5382.
Si R, Zhang Q, Cabrera J, Zheng Q, Tsuji-Hosokawa A, Watanabe M J Am Heart Assoc. 2020; 9(24):e018327.
PMID: 33307937 PMC: 7955394. DOI: 10.1161/JAHA.120.018327.
Vitte J, Michel M, Mezouar S, Diallo A, Boumaza A, Mege J Front Immunol. 2020; 11:2159.
PMID: 32983179 PMC: 7484884. DOI: 10.3389/fimmu.2020.02159.
Chloroquine differentially modulates coronary vasodilation in control and diabetic mice.
Zhang Q, Tsuji-Hosokawa A, Willson C, Watanabe M, Si R, Lai N Br J Pharmacol. 2019; 177(2):314-327.
PMID: 31503328 PMC: 6989957. DOI: 10.1111/bph.14864.